NCT06319313 2024-03-20Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung CancerShanghai JMT-Bio Inc.Phase 2/3 Not yet recruiting534 enrolled
NCT01642004 2022-12-28Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)Bristol-Myers SquibbPhase 3 Completed272 enrolled 23 charts